Dr Lipid
@drlipid.bsky.social
Longtime Lipid/Lipoprotein Educator with an extensive resume including Associate Editor of Journal of Clinical Lipidology. Practiced in NJ for 37 years. Has done 4000 lectures in all 50 states & authored many publications. Has two major awards from NLA
Happy New Year to Lipidaholics - First lesson of 2026 providing some basics on Low Density Lipoproteins (LDLs): (1) Structure (2) Properties (3) Particle & cholesterol metrics (4) Changing apoB mass metrics (mg/dL) to particle numbers (nmol/L). @nationallipid.bsky.social @aspcardio.bsky.social
January 1, 2026 at 4:36 PM
Happy New Year to Lipidaholics - First lesson of 2026 providing some basics on Low Density Lipoproteins (LDLs): (1) Structure (2) Properties (3) Particle & cholesterol metrics (4) Changing apoB mass metrics (mg/dL) to particle numbers (nmol/L). @nationallipid.bsky.social @aspcardio.bsky.social
I am happy to be included on this excellent 2025 Wrap Up with various podcast clips by some key experts
@theproof discussing ASCVD, Lipids, Lipid targets, Lp(a), Hypertension, Keto trial, Nutrients, Cancer and much more. youtu.be/GMB9zFdaiaA?... @nationallipid.bsky.social @aspcardio.bsky.social
@theproof discussing ASCVD, Lipids, Lipid targets, Lp(a), Hypertension, Keto trial, Nutrients, Cancer and much more. youtu.be/GMB9zFdaiaA?... @nationallipid.bsky.social @aspcardio.bsky.social
December 30, 2025 at 5:05 PM
I am happy to be included on this excellent 2025 Wrap Up with various podcast clips by some key experts
@theproof discussing ASCVD, Lipids, Lipid targets, Lp(a), Hypertension, Keto trial, Nutrients, Cancer and much more. youtu.be/GMB9zFdaiaA?... @nationallipid.bsky.social @aspcardio.bsky.social
@theproof discussing ASCVD, Lipids, Lipid targets, Lp(a), Hypertension, Keto trial, Nutrients, Cancer and much more. youtu.be/GMB9zFdaiaA?... @nationallipid.bsky.social @aspcardio.bsky.social
For Lipidologists and lipid interested folks: More on Lysine binding domains on apo(a) component of Lp(a) and the assay measuring oxPL-apoB (oxidized phospholipids on apoB) @nationallipid.bsky.social @aspcardio.bsky.social @escardio.bsky.social @familyheartfdn.bsky.social
December 23, 2025 at 5:30 PM
For Lipidologists and lipid interested folks: More on Lysine binding domains on apo(a) component of Lp(a) and the assay measuring oxPL-apoB (oxidized phospholipids on apoB) @nationallipid.bsky.social @aspcardio.bsky.social @escardio.bsky.social @familyheartfdn.bsky.social
More on my LDL discussion series: Enjoy my graphics as they speak for themselves @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social @escardio.bsky.social
December 14, 2025 at 12:54 AM
More on my LDL discussion series: Enjoy my graphics as they speak for themselves @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social @escardio.bsky.social
Among 450,177 individuals with fibroids and 2,250,885 controls (mean age: 41 years, SD 6.3), uterine fibroids were associated with sustained increased ASCVD risks up to 10 years postdiagnosis, supporting targeted ASCVD prevention: OPEN ACCESS www.ahajournals.org/doi/10.1161/JAHA.125.044014
December 11, 2025 at 2:18 PM
Among 450,177 individuals with fibroids and 2,250,885 controls (mean age: 41 years, SD 6.3), uterine fibroids were associated with sustained increased ASCVD risks up to 10 years postdiagnosis, supporting targeted ASCVD prevention: OPEN ACCESS www.ahajournals.org/doi/10.1161/JAHA.125.044014
Part 2 of the AMA I did with @_CynthiaThurlow www.cynthiathurlow.com/post/ep-527-...
Ep. 527 HRT Changes Your Lipids More Than You Think – The Surprising Truth About Menopause & Heart Disease with Dr. Thomas Dayspring
I am honored to have Dr. Tom Dayspring join me again today for another AMA session. He and I have done eight podcasts before, and this is a continuation of our last Ask Me Anything episode. Dr Dayspri...
www.cynthiathurlow.com
December 10, 2025 at 6:12 PM
Part 2 of the AMA I did with @_CynthiaThurlow www.cynthiathurlow.com/post/ep-527-...
For those interested in quickly increasing their understanding of lipids and lipoproteins take a peak at this site called Lipid Curious" by endocrinologist/Lipidologist Vishnu Priya Pulpati that offers 10 concise podcasts www.buzzsprout.com/2508586/epis... or podcastindex.org/podcast/7364...
LipidCurious
Podcast dedicated to demystifying lipids for medical boards and real-world clinical practice.
www.buzzsprout.com
December 6, 2025 at 6:13 PM
For those interested in quickly increasing their understanding of lipids and lipoproteins take a peak at this site called Lipid Curious" by endocrinologist/Lipidologist Vishnu Priya Pulpati that offers 10 concise podcasts www.buzzsprout.com/2508586/epis... or podcastindex.org/podcast/7364...
New Book with a very appropriate title (Graphic 1). The dilemma of science today are the Internet Charlatans - They have now also left social media and invaded the FDA and HHS hachettebookgroup.com/titles/moise...
December 6, 2025 at 12:51 AM
New Book with a very appropriate title (Graphic 1). The dilemma of science today are the Internet Charlatans - They have now also left social media and invaded the FDA and HHS hachettebookgroup.com/titles/moise...
Interesting report on how statins may cause myopathic symptoms medicalxpress.com/news/2025-11... @nationallipid.bsky.social @aspcardio.bsky.social @escardio.bsky.social @familyheartfdn.bsky.social
How statins harm muscles—and how to stop it
Statins have transformed heart health, saving millions of lives by lowering cholesterol and reducing the risk of heart attacks and strokes. But for many patients, these drugs come with a troubling dow...
medicalxpress.com
November 28, 2025 at 5:49 PM
Interesting report on how statins may cause myopathic symptoms medicalxpress.com/news/2025-11... @nationallipid.bsky.social @aspcardio.bsky.social @escardio.bsky.social @familyheartfdn.bsky.social
Amazing how many pertinent lipid/lipoprotein issues my RVA-located neighbor, Cynthia Thurlow & I tackled on an important topic. Viewers also see a word for word transcription for review podcasts.apple.com/us/podcast/e... @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social
Ep. 523 This Is Why Your Cholesterol Shifts in Midlife – The Best Strategies to Reduce Risk & Improve Vascular Health with Dr. Thomas Dayspring
Podcast Episode · Everyday Wellness: Midlife Hormones, Health, and Science for Women 35+ · 11/26/2025 · 1h 11m
podcasts.apple.com
November 27, 2025 at 6:25 PM
Amazing how many pertinent lipid/lipoprotein issues my RVA-located neighbor, Cynthia Thurlow & I tackled on an important topic. Viewers also see a word for word transcription for review podcasts.apple.com/us/podcast/e... @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social
LDL Education Post 2: More important LDL facts that for the most part are not taught, hard to find and therefore so frequently mischaracterized (misused) on social media and sadly in too many manuscripts. Enjoy. @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social
November 24, 2025 at 12:26 AM
LDL Education Post 2: More important LDL facts that for the most part are not taught, hard to find and therefore so frequently mischaracterized (misused) on social media and sadly in too many manuscripts. Enjoy. @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social
LDL education: (1) never confuse the term LDL, the name of a specific lipoprotein with LDL-P a particle concentration metric. (2) LDL is named by its density via ultracentrifugation (3) What is LDL size, peak particle size or Pattern? (4) How many LDL particles exist per liter of plasma?
November 23, 2025 at 1:18 AM
LDL education: (1) never confuse the term LDL, the name of a specific lipoprotein with LDL-P a particle concentration metric. (2) LDL is named by its density via ultracentrifugation (3) What is LDL size, peak particle size or Pattern? (4) How many LDL particles exist per liter of plasma?
Food for thought - Is long-term melatonin use safe? New study highlights heart risks cardiovascularbusiness.com/topics/clini... @nationallipid.bsky.social @aspcardio.bsky.social @menopausesociety.bsky.social
Is long-term melatonin use safe? New study highlights heart risks
Taking melatonin for a year could increase a person's risk of developing heart failure by 90%. While more research is still needed to confirm these findings, the data suggest patients should think twi...
cardiovascularbusiness.com
November 15, 2025 at 4:22 PM
Food for thought - Is long-term melatonin use safe? New study highlights heart risks cardiovascularbusiness.com/topics/clini... @nationallipid.bsky.social @aspcardio.bsky.social @menopausesociety.bsky.social
For those who missed the webinar featuring preventive neurologist @KellyannNiotis and myself discussing brain and heart issues in peri- & menopausal women here is the link us06web.zoom.us/rec/share/WQ... @nationallipid.bsky.social @aspcardio.bsky.social @menopausesociety.bsky.social
November 13, 2025 at 5:53 PM
For those who missed the webinar featuring preventive neurologist @KellyannNiotis and myself discussing brain and heart issues in peri- & menopausal women here is the link us06web.zoom.us/rec/share/WQ... @nationallipid.bsky.social @aspcardio.bsky.social @menopausesociety.bsky.social
For those inquisitive about the next CETP inhibitor, obicetrapib, the following release from @NewAmsPharma will keep you up to date ir.newamsterdampharma.com/news-release... @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results | NewAmsterdam Pharma
– Marketing Authorization Applications for obicetrapib and FDC of obicetrapib plus ezetimibe accepted for review by European Medicines Agency – – BROOKLYN and BROADWAY pooled MACE analysis published i...
ir.newamsterdampharma.com
November 6, 2025 at 1:02 AM
For those inquisitive about the next CETP inhibitor, obicetrapib, the following release from @NewAmsPharma will keep you up to date ir.newamsterdampharma.com/news-release... @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social
An alert and invitation to join me and my tag-team partner Dr Kellyann Niotis in a live virtual "fireside chat" with @jfwellness1 called Protecting Your Brain & Heart in Midlife & Beyond - Register at us06web.zoom.us/webinar/regi...
Welcome! You are invited to join a webinar: Protecting Your Brain & Heart in Midlife & Beyond. After registering, you will receive a confirmation email about joining the webinar.
Join us for a powerful conversation with Coach Jill Foos, and two leading experts—Dr. Kellyann Niotis, the first fellowship-trained preventive neurologist, and Dr. Thomas Dayspring, internationally re...
us06web.zoom.us
November 3, 2025 at 6:23 PM
An alert and invitation to join me and my tag-team partner Dr Kellyann Niotis in a live virtual "fireside chat" with @jfwellness1 called Protecting Your Brain & Heart in Midlife & Beyond - Register at us06web.zoom.us/webinar/regi...
LabCorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes of cognitive decline for patients 55 years and older. www.fiercebiotech.com/medtech/labc...
Labcorp signs on to carry Roche's newly FDA-cleared Alzheimer's blood test
Labcorp pla | Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes of cognitive decline for patients 55 years and older.
www.fiercebiotech.com
October 29, 2025 at 6:09 PM
LabCorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes of cognitive decline for patients 55 years and older. www.fiercebiotech.com/medtech/labc...
www.youtube.com/watch?v=hxtPuBCXW_Y @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social @menopausesociety.bsky.social
The limitations of using HDL cholesterol as a marker for heart health | Tom Dayspring
YouTube video by Peter Attia MD
www.youtube.com
October 28, 2025 at 3:29 PM
For those of you who missed @PeterAttiaMD on 60 minutes last night - enjoy Dr. Attia Will See You Now | Sunday at www.youtube.com/watch?v=li4jARm9t40 @nationallipid.bsky.social @aspcardio.bsky.social
Dr. Attia Will See You Now | Sunday on 60 Minutes
YouTube video by 60 Minutes
www.youtube.com
October 27, 2025 at 7:20 PM
For those of you who missed @PeterAttiaMD on 60 minutes last night - enjoy Dr. Attia Will See You Now | Sunday at www.youtube.com/watch?v=li4jARm9t40 @nationallipid.bsky.social @aspcardio.bsky.social
Did everyone catch @PeterAttiaMD on the today show yesterday discussing "How to Live Longer and Stay Young Physically and Mentally" - www.today.com/video/how-to-live-longer-and-stay-young-physically-and-mentally-250554437856?search=peter%20attia @nationallipid.bsky.social @aspcardio.bsky.social
How to Stay Young Physically and Mentally as You Age
Author, podcaster and longevity expert Dr. Peter Attia joins TODAY to share how you can live longer and what you can do now to stay young physically and mentally as you age. He explains how even minim...
www.today.com
October 25, 2025 at 12:51 PM
Did everyone catch @PeterAttiaMD on the today show yesterday discussing "How to Live Longer and Stay Young Physically and Mentally" - www.today.com/video/how-to-live-longer-and-stay-young-physically-and-mentally-250554437856?search=peter%20attia @nationallipid.bsky.social @aspcardio.bsky.social
Waist Loss Only Part of Semaglutide’s Power conexiant.com/cardiology/a... Open access pdf at www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01375-3/fulltext @nationallipid.bsky.social @aspcardio.bsky.social @escardio.bsky.social
Waist Loss Only Part of Semaglutide’s Power
Semaglutide lowered cardiovascular events in patients with overweight or obesity without diabetes, independent of weight loss.
conexiant.com
October 23, 2025 at 11:23 PM
Waist Loss Only Part of Semaglutide’s Power conexiant.com/cardiology/a... Open access pdf at www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01375-3/fulltext @nationallipid.bsky.social @aspcardio.bsky.social @escardio.bsky.social
Large study investigated different classes of BP drugs & the risk of incident dementia. Conclusion: physicians & patients should consider the reduced risk of all-cause dementia and Vascular Dementia with ARB compared with ACE-I in their risk–benefit assessment. academic.oup.com/ageing/artic...
Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study
AbstractBackground. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-II receptor blockers (ARBs) are first-line antihypertensive drugs for
academic.oup.com
October 20, 2025 at 1:58 PM
Large study investigated different classes of BP drugs & the risk of incident dementia. Conclusion: physicians & patients should consider the reduced risk of all-cause dementia and Vascular Dementia with ARB compared with ACE-I in their risk–benefit assessment. academic.oup.com/ageing/artic...
Want to listen to the one and only fellowship trained preventive Neurologist? Podcast is "Brain Health & Preventative Neurology" with Dr. Kellyann Niotis - Who will also be speaking
@nationallipid.bsky.social meeting on Saturday. open.spotify.com/episode/4fpt...
@nationallipid.bsky.social meeting on Saturday. open.spotify.com/episode/4fpt...
319: Brain Health & Preventative Neurology with Dr. Kellyann Niotis
open.spotify.com
October 16, 2025 at 1:44 PM
Want to listen to the one and only fellowship trained preventive Neurologist? Podcast is "Brain Health & Preventative Neurology" with Dr. Kellyann Niotis - Who will also be speaking
@nationallipid.bsky.social meeting on Saturday. open.spotify.com/episode/4fpt...
@nationallipid.bsky.social meeting on Saturday. open.spotify.com/episode/4fpt...
Want to know where Lipidology is going and some of the new drugs? Check out this open access chat by two giants in the field entitled "Pharmacotherapy Development and Trends in Lipidology: An Expert Discussion" www.lipidjournal.com/article/S1933-2874(25)00423-4/fulltext @nationallipid.bsky.social
Pharmacotherapy Development and Trends in Lipidology: An Expert Discussion
Cardiovascular diseases are leading causes of morbidity and mortality in the United
States and globally. Atherosclerotic cardiovascular diseases (ASCVD), such as coronary
heart disease and cerebrovasc...
www.lipidjournal.com
October 10, 2025 at 3:04 PM
Want to know where Lipidology is going and some of the new drugs? Check out this open access chat by two giants in the field entitled "Pharmacotherapy Development and Trends in Lipidology: An Expert Discussion" www.lipidjournal.com/article/S1933-2874(25)00423-4/fulltext @nationallipid.bsky.social
Good news: except for those who think lowering cholesterol is averse to the brain health - lipid Rx lessens AD risk - doi.org/10.1002/alz.... @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social @menopausesociety.bsky.social
Cholesterol‐lowering drug targets reduce risk of dementia: Mendelian randomization and meta‐analyses of 1 million individuals
INTRODUCTION We tested whether genetically proxied non-high-density lipoprotein cholesterol (non-HDL-C)–lowering drug targets reduce risk of all-cause dementia. METHODS We included 1,091,775 indiv...
doi.org
October 8, 2025 at 1:50 PM
Good news: except for those who think lowering cholesterol is averse to the brain health - lipid Rx lessens AD risk - doi.org/10.1002/alz.... @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social @menopausesociety.bsky.social